An experimental Ebola vaccine tested on humans in Guinea in the waning days of the West African epidemic has been shown to provide 100 percent protection against the lethal disease.

The vaccine has not yet been approved by any regulatory authority.

But it is considered so effective that an emergency stockpile of 300 000 doses has already been created for use should an outbreak flare up again.

Discovered in the DRC in 1976, the grotesque nature of victims  deaths — copious hemorrhaging from every orifice — has given Ebola a frightening reputation.

The huge, explosive 2014 outbreak that took 11,000 lives in Africa and spread overseas, killing a handful of people in Europe and the United States provided the political and economic drive to make an effective vaccine.

The post Effective anti Ebola vaccine developed appeared first on Jean-Jacques Cornish.